- Home
- VRPX
as 12-18-2024 11:59am EST
Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.
| Founded: | 2016 | Country: | United States |
| Employees: | N/A | City: | BERWYN |
| Market Cap: | 3.7M | IPO Year: | 2021 |
| Target Price: | N/A | AVG Volume (30 days): | 10.4M |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -5.91 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.29 - $5.48 | Next Earning Date: | 11-14-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Virpax Pharmaceuticals Inc. News
VRPX Breaking Stock News: Dive into VRPX Ticker-Specific Updates for Smart Investing
MT Newswires
a month ago
Sector Update: Health Care Stocks Rise Friday Afternoon
MT Newswires
a month ago
Sector Update: Health Care
MT Newswires
a month ago
Virpax Pharmaceuticals Shares Surge After Reporting Positive Results for Prospective Pain Drug
Business Wire
a month ago
Virpax Announces Positive Results for the Swine Model Dose Range Finding Study for Probudur™
Business Wire
a month ago
Virpax Announces Agreement with the U.S. Department of Health and Human Services for the Developmental Extension for NES100 Towards IND for Acute and Chronic Non-Cancer Pain Alternative
GlobeNewswire
a month ago
Spartan Capital Securities, LLC Serves as Sole Placement Agent in Virpax Pharmaceuticals, Inc.'s $5.0 Million Public Offering
Business Wire
a month ago
Virpax Pharmaceuticals, Inc. Announces Closing of $5.0 Million Public Offering of Common Stock and Pre-Funded Warrants
Business Wire
a month ago
Virpax Pharmaceuticals, Inc. Announces Pricing of $5.0 Million Public Offering of Common Stock and Pre-Funded Warrants
Compare VRPX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "VRPX Virpax Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.